Article

COX‐2 expression during 4‐nitroquinoline 1‐oxide induced rat tongue carcinogenesis

Basic and Applied Pathology 03/2009; 2(1):9 - 14. DOI: 10.1111/j.1755-9294.2009.01031.x

ABSTRACT Background and aims: This study was undertaken to investigate, by immunohistochemistry, the expression of cyclooxygenase-2 (COX-2) during 4-nitroquinoline 1-oxide (4NQO)-induced rat tongue carcinogenesis. Methods: Male Wistar rats were distributed into three groups of 10 animals each and treated with 50 ppm 4NQO solution through their drinking water for 4, 12, and 20 weeks. Ten animals were used as negative control. Results: Although no histopathological abnormalities were induced in the epithelium after 4 weeks of carcinogen exposure, COX-2 was expresssed in some cells of the ‘normal’ oral epithelium in the superficial layer. In pre-neoplastic lesions at 12 weeks following carcinogen exposure, the levels of COX-2 were increased (P < 0.05) when compared to negative control. In well-differentiated squamous cell carcinoma induced after 20 weeks of treatment with 4NQO, the same picture occurred when compared to negative control. Weak immunoreactivity for COX-2 was observed in the negative control group being restricted to basal layer of the oral epithelium. Conclusions: Taken together, our results support the idea that expression of COX-2 plays a crucial role during malignant transformation being closely related to neoplastic conversion of the oral mucosa cells.

0 Followers
 · 
71 Views
 · 
2 Downloads
  • [Show abstract] [Hide abstract]
    ABSTRACT: A study was conducted in rats with early tongue carcinoma induced by 4-nitroquinoline 1-oxide (4NQO), in order to investigate the early diagnosis of malignant potential of epithelial dysplasia. The rat tongue lesions were classified by their severity into three groups corresponding to early cancer, dysplasia and no change. The grade of epithelial changes was determined according to 13 items of WHO Epithelial Dysplasia Criteria. The expression levels of p53 and Bcl-2 proteins were detected immunohistochemically, and apoptotic cells were detected using the TUNEL method. In addition, a p53 mutation by lesions was detected. The expression ratio of p53 protein was high in dysplasia, and the ratio of Bcl-2 protein was high in early cancer and dysplasia. The TUNEL-positive cells were observed primarily in the granular layers of the no change cells, and their numbers decreased as the cells shifted to the early cancer stage. The p53 mutation was detected using a microdissection method in dysplasia, where it was found in three out of nine lesions. All the mutations in dysplasia detected were on the same codon that was found to be mutated in the early cancer. These results indicate that the association between the p53 mutation and histological changes in carcinogenesis epithelial dysplasia is strong, and that both the identification of p53- and Bcl-2-positive epithelium, and decrease in the TUNEL positive ratio, were useful for the diagnosis of the malignant potential of precancerous lesions.
    Oral Oncology 10/2002; 38(6):562-73. DOI:10.1016/S1368-8375(01)00119-1 · 3.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Taking into consideration that glutatione S-transferase (GST) and cellular proliferation play a crucial role during carcinogenesis, the goal of this study was to investigate the expression of placental GST, called GST-P, and proliferating cellular nuclear antigen (PCNA) by means of immunohistochemistry during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide (4NQO). This is a useful model for studying oral squamous cell carcinoma phase by phase. Male Wistar rats were distributed into three groups of 10 animals each and treated with 50 ppm 4NQO solution by drinking water for 4, 12 or 20 weeks. Ten animals were used as negative control. GST-P positive foci were detected in non-neoplastic oral cells at 4 weeks of 4NQO administration. In the same way, GST-P positive cells were detected in pre-neoplastic lesions and squamous cell carcinomas induced after 12 and 20 weeks-treatment, respectively. None of the control animals expressed GST-P positive cells. Regarding cellular proliferation, PCNA positive nuclei were higher at 12 and 20 weeks following 4NQO exposure (p<0.05) when compared to negative control. These results suggest that the expression of GST-P is correlated with cellular proliferation, in which GST-P is associated with risk and progression of oral cancer, whereas PCNA is closely involved during neoplastic conversion.
    Experimental and Toxicologic Pathology 10/2007; 59(1):61-8. DOI:10.1016/j.etp.2007.02.010 · 2.01 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: ABSTRACT Cyclooxygenase (COX) catalyzes the formation of prostaglandins (PG) from arachidonic acid. A large body of evidence has accumulated to suggest that COX-2, the inducible form of COX, is important in carcinogenesis. In this study, we determined whether (1) COX-2 was overexpressed in squamous cell carcinoma of the head and neck (HNSCC) and whether (2) retinoids, a class of chemopreventive agents, blocked epidermal growth factor (EGF)-mediated activation of COX-2 expression. Levels of COX-2 mRNA were determined in 15 cases of HNSCC and 10 cases of normal oral mucosa. Nearly a 100-fold increase in amounts of COX-2 mRNA was detected in HNSCC. By immunoblot analysis, COX-2 protein was detected in 6 of 6 cases of HNSCC but was undetectable in normal mucosa. Because retinoids protect against oral cavity cancer, we investigated whether retinoids could suppress EGF-mediated induction of COX-2 in cultured oral squamous carcinoma cells. Treatment with EGF led to increased levels of COX-2 mRNA, COX-2 protein, and synthesis of PG. These effects were suppressed by a variety of retinoids. Based on the results of this study, it will be important to establish whether newly developed selective COX-2 inhibitors are useful in preventing or treating HNSCC. Moreover, the anticancer properties of retinoids may be due, in part, to inhibition of COX-2 expression. Combining a retinoid with a selective COX-2 inhibitor may be more effective than either agent alone in preventing cancer of the upper aerodigestive tract.
    Annals of the New York Academy of Sciences 02/2006; 889(1):62 - 71. DOI:10.1111/j.1749-6632.1999.tb08724.x · 4.31 Impact Factor
Show more

Preview

Download
2 Downloads